Becker's Healthcare May 7, 2024
Life sciences company Geneoscopy received FDA approval for its noninvasive colorectal cancer screening test, ColoSense.
ColoSense is the first noninvasive colorectal cancer screening test to offer a view of disease activity through RNA biomarkers, according...